Robin Monotti + Cory Morningstar
69.7K subscribers
15.5K photos
8.62K videos
624 files
29.7K links
Official Robin Monotti + Cory Morningstar
Donations:
robinmonotti.substack.com/
www.patreon.com/CoryMorningstar
Group is @robinmggroup
We don't DM from this channel account.
Rule: Be polite & respectful.
Download Telegram
Forwarded from freedomtirade
Media is too big
VIEW IN TELEGRAM
Robin Monotti and Robert Kennedy with stern words comparing the energy of our time to the period of
1933 -1945, a time of division, hatred and discord.

ODYSEE video 12min:
https://odysee.com/@FreedomTirade:f/turn-this-thing-off:b

Bill Gates paid billions to silence dissent and suppress cheap medicines for Covid.

Eric Schmidt of Google claims the Resistance is 10-20% strong but the size of ever growing protests across the world tell a different story as more and more jabbed people realise they were conned by the most deadly pyramid scheme scam in Medical and Political History.

Pursue HEALTH... Resist TYRANNY
https://t.me/FreedomTirade
Forwarded from freedomtirade
Media is too big
VIEW IN TELEGRAM
"The best value 18 minutes you’ll spend"
-Dr Mike Yeadon

"Share THIS with your sceptical friends. They know, you know. They do.They don’t want to admit it, they are too frightened.
Tell them not to be, but to rejoin hands & arms with us all & tell the global predators -
“they can stick their new world order up their ****"

"GOD is FIGHTING with the DEVIL and the battlefield is the HEART OF MAN"
-Dostoyevsky
Nothing could be more literally true than vax-carditis.

Peter McCullough, Robin Monotti, Mattias Desmet and a handful of real life heroes point to the battles we face , and the villains we must defeat.

Battlefield HEART
Odysee video 18 minutes
https://odysee.com/@FreedomTirade:f/god-devil:9

It is time to take back our inalienable rights from those who wish to dominate the entire human race and turn us into disposable slaves of an immortal AI Diktator.

Pursue HEALTH.... RESIST Tyranny
https://t.me/FreedomTirade
Forwarded from Dr. Vladimir Zelenko (Zelenko Protocol) (Zev Zelenko)
Many Single Strand RNA viruses (ssRNA) use RNA dependent RNA polymerase (RdRp) to replicate their genetic material. This is required to make more copies of virus and spread to other sells.

These viruses include:

Covid-19 (all strains)
Influenza
RSV
Hantavirus
Ebola virus
Marburg virus

The use of Zinc Ionophores and Zinc will treat these viruses.

Zinc Ionophores include:

Hydroxychloroquine
Ivermectin
Quercetin
EGCG

In other words, we can prevent and treat the above viruses with cheap, oral, effective, and safe drugs. Some of which are over the counter.

Please study this text and understand what it means.

Vladimir Zev Zelenko MD

https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC7365891/

https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC5589696/#!po=0.746269

https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC3787895/

https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC4966622/

https://pubs.acs.org/doi/10.1021/acsinfecdis.0c00554
There is a story circulating about graphene oxide in the vaccines, attached to me.
I want you to know that I have not commissioned anything, so this is fake.
Best wishes
Mike

Dr Mike Yeadon
This media is not supported in your browser
VIEW IN TELEGRAM
100x over what this retired Canadian police officer asks.
“Stand down. Do not take violent action against peaceful people of your own community”
Best wishes
Mike
Media is too big
VIEW IN TELEGRAM
I’m in regular contact with the speaker, Denis Rancourt.
Among other things, he convinced me that if the new virus exists, it’s not lethal, because there was no increase in all causes mortality in 2020.
Bottom line, we’ve all been lied to for at least two years.
Best wishes
Mike
This media is not supported in your browser
VIEW IN TELEGRAM
With fellow citizens like this, we will not be defeated ❤️
Please consider disconnecting your TV permanently.
Best wishes
Mike
This media is not supported in your browser
VIEW IN TELEGRAM
"The most serious challenge facing our illusory democracy (on stolen lands), is the fact that Justin Trudeau's allegiance is to the queen - not to people." [Morningstar, Twitter]

The Emergencies Act is carried out via the Attorney General and the President of the Queen's Privy Council in Canada (Also called "Her Majesty's Privy Council for Canada").
Must watch for Canadians. This excellent interview with Mathew Ehet discusses "the British hands in global affairs today". (This follows the equally excellent interview with Alex Thomson). (Includes Trudeau oath.)

https://www.bitchute.com/video/0XJXsLc1sQcl/
There is an imperative to shift focus. Missing from #FreedomConvoy dissent is rule of British Crown/British Empire - architect/head of Great Reset convened via the World Economic Forum platform.
Canadian Civil Liberties Association:

"The federal government has not met the threshold necessary to invoke the Emergencies Act. This law creates a high and clear standard for good reason: the Act allows government to bypass ordinary democratic processes. This standard has not been met.

The Emergencies Act can only be invoked when a situation "seriously threatens the ability of the Government of Canada to preserve the sovereignty, security and territorial integrity of Canada" & when the situation "cannot be effectively dealt with under any other law of Canada."

Governments regularly deal with difficult situations, and do so using powers granted to them by democratically elected representatives. Emergency legislation should not be normalized. It threatens our democracy and our civil liberties."
Anyone still marvelling at the “warp speed” of development of the Covid19 “vaccines”?
So what’s involved? Here’s a summary from someone who spent more than 35y in the pharmaceutical industry.
It’s not me, by the way.
This person has the experience to back up their view that the required steps simply cannot be done in a year or less. You’ve been lied to & the alleged “vaccines” have not not not been tested at all adequately, but the processes of manufacture are also way outside the guardrails of quality & consistency.
It’s hardly surprising that there have been so many injuries & deaths.
Best wishes
Mike

1. Licensing under the conditional marketing authorisation (CMA) provisions requires submission of a conditional marketing application (CMA) by the company seeking to market the product.
2. Provisions in the CMA do not relieve the EMA from proper review and evaluation of the common technical document (eCTD) as submitted in the application, to assure safety, efficacy, and quality standards are met.
3. The lifecycle of a development programme for a medicinal product begins with pre-clinical assessment of a batch (lot), or batches of the active pharmaceutical ingredient (API) at small (pilot) scale. Batches are typically pre-GMP.
4. Data relating to production must be carefully recorded and collected, including but not limited to, manufacturing processes and procedures, suppliers, service providers (manufacturers – eg Lonza, Oxford BioMedica), material specifications, development protocols, and analytical methods.
5. These data must be included in Module 3 (chemistry, manufacturing & controls) section of the eCTD when any submission is made. Similarly, all data applicable to Module 4 (safety) must be included in any future submission.
6. Regulatory (EMA) evaluation and approval to conduct clinical trials in humans will (should) have been based on these data. Failure to carry out this evaluation, prior to human administration, constitutes gross negligence. The average timescale for this initial stage is 2 to 3 years.
7. For the next stage in the development lifecycle, studies in humans, GMP is mandated for production of all of test material. The batch size will still be small given the relative low number of subjects receiving drug product. Further safety data must be generated for each batch, to confirm there has been no change to the character of the final molecule. At this stage, Module 5 (clinical) data from the studies in humans is added to the eCTD for future submission.
8. It is essential that the phases of clinical trials are carried out sequentially. Phase 1 production used in humans must be proven safe before moving to a larger scale for phase 2 studies within the broader patient population. Ditto for phase 3 studies if scale up is required.   There is a regulatory limit to scale up set at a factor of 2.5X the existing batch. When phase 3 studies are complete, all data pertinent to the three Modules of the eCTD must be submitted electronically to yourselves at EMA.
9. This stage of clinical development typically takes 5 to 8 years.
10. Once the eCTD is submitted to EMA, the regulatory clock begins ticking. During this time, all sections of the eCTD are evaluated by suitably qualified staff, and a list of unanswered questions prepared for discussion and resolution with the applicant.
11. A critical element of Module 3 is the integrity of the end-to-end supply chain that has been constructed during the development programme, and its ability to produce product of consistent quality throughout its lifetime. This is based on every manufacturer of drug substance and drug product, as a minimum, applying for a manufacturing authorisation (MA) for the product, and that the product application is successful and added to their existing license.
12. This can only be effected following a thorough inspection and written report by suitably qualified EMA staff, and remediation of any issues raised by the applicant. This typically take 6 to 12 months.
During this time and following a successful inspection, the applicant typically produces 3 batches of stock at the validated scale, in anticipation of approval and launch.
13. The conclusion is that the development programme lifecycle of pre-clinical, clinical, and full-scale production and regulatory evaluation cannot safely be condensed into 12 months or less. Anything less than 5 years would raise eyebrows, and 8 – 10 years a more reasonable expectation.
14. In addition, consider that the SARS-CoV-2 injections are gene therapies, classed under the heading of advanced therapy medicinal products (ATMPs).
15. Procedural advice on the evaluation of advanced therapies specifies the need for a Committee for Advanced Therapies (CAT) to lead the scientific evaluation, stating: “The evaluation of advanced therapy medicinal products often requires very specific expertise, which goes beyond the traditional pharmaceutical field and covers areas bordering on other sectors such as biotechnology and medical devices.”
16. This would further extend the development lifecycle timeline.